Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine

Clinical Pharmacology and Therapeutics
C Y WuV J Wacher

Abstract

The low and variable bioavailability of cyclosporine has been attributed to poor absorption. However, recent studies have suggested that intestinal first-pass metabolism exerts a significant effect on bioavailability. We describe theory and methods to differentiate the contribution from oral absorption and intestinal and hepatic metabolism to overall cyclosporine bioavailability. Analysis of data from previous studies in our laboratories shows that in the absence of intestinal metabolism, cyclosporine absorption from its presently available dosage form averages at least 65% +/- 12% in healthy volunteers and 77% +/- 19% in kidney transplant patients. Analysis also suggests that the extraction ratio for cyclosporine in the gut is approximately twice the hepatic extraction and that cyclosporine absorption does not present a problem, with an average of 86% of the drug absorbed intact from its commercially available product in healthy volunteers. The boundary condition analysis described should have broad application in the differentiation of factors responsible for poor bioavailability.

References

Dec 1, 1979·Journal of Pharmacokinetics and Biopharmaceutics·B G GustavssonO E Almersjö
Dec 14, 1991·Lancet·J C KolarsP B Watkins
Apr 1, 1989·British Journal of Clinical Pharmacology·S K GuptaM Rowland
Jan 1, 1972·Journal of Pharmaceutical Sciences·M Rowland
Jul 1, 1995·Clinical Pharmacology and Therapeutics·D Y GomezL Z Benet
Aug 1, 1994·Pharmacogenetics·P B Watkins

❮ Previous
Next ❯

Citations

Jul 2, 2009·Pharmaceutical Research·Sarah Shugarts, Leslie Z Benet
Oct 31, 2009·Molecular Pharmaceutics·Leslie Z Benet
May 23, 1998·Annual Review of Pharmacology and Toxicology·K E Thummel, G R Wilkinson
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·J H Lin, A Y Lu
Jun 27, 2013·BMC Pharmacology & Toxicology·David G Levitt
Apr 22, 2009·The AAPS Journal·Masoud JameiGeoffrey Tucker
Jan 5, 2007·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Toshiro NiwaAkira Takagi
Sep 15, 2009·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Takashi Mizuma
Dec 13, 2006·Drug Metabolism and Drug Interactions·Srirangam RameshYamsani Madhusudan Rao
Apr 1, 2014·The Veterinary Record·Peter Forsythe, Sue Paterson
May 15, 2013·Journal of Aerosol Medicine and Pulmonary Drug Delivery·T E CorcoranB A Johnson
May 13, 1998·British Journal of Clinical Pharmacology·H H KupferschmidtS Krähenbühl
Jan 6, 2015·Expert Opinion on Drug Delivery·Irina CherniakovAmnon Hoffman
Feb 3, 2015·Expert Opinion on Drug Delivery·Saba KhanJaved Ali
Jun 21, 2005·British Journal of Clinical Pharmacology·Mari ThörnLars Lööf
Sep 21, 2007·Clinical and Experimental Pharmacology & Physiology·Roberto CanaparoGian Paolo Zara
Nov 14, 2008·Cellular & Molecular Biology Letters·Aleksander Czogalla
Jan 9, 1998·Drug Metabolism Reviews·C L ZimmermanY K Pithavala
Jul 16, 2008·Expert Opinion on Drug Metabolism & Toxicology·Teruo Murakami, Mikihisa Takano
Jul 21, 2009·Expert Opinion on Drug Metabolism & Toxicology·Thierry LavéMalcolm Rowland
Oct 31, 2007·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·H Lennernäs
Feb 24, 2011·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Hee Jeong AhnIm-Sook Song
Dec 14, 2004·The Annals of Pharmacotherapy·Raymond G Morris
Oct 1, 1996·Journal of Pharmacokinetics and Biopharmaceutics·G R Wilkinson
Jul 5, 2006·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Paolo Fusar-PoliPierluigi Politi
Oct 29, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Thomas D NolinGary R Matzke
Apr 6, 2005·The Journal of Pharmacy and Pharmacology·Hans Lennernäs, Bertil Abrahamsson
Jan 8, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Tahnee J DeningClive A Prestidge
Jul 25, 2000·Journal of Pharmaceutical Sciences·W N Charman
Jan 10, 2002·Journal of Pharmaceutical Sciences·Guanfa GanRonald J Sawchuk
Jun 13, 1998·Transplantation·B KaplanS P Mulgaonkar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

© 2021 Meta ULC. All rights reserved